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Introduction
Epithelial ovarian cancer is the most lethal and second
most common gynecologic cancer in the United States.
Previous studies have demonstrated the favorable prog-
nostic value of tumor infiltrating lymphocytes in this
disease. The objective of this study was to evaluate the
prognostic value and the biological correlates for lym-
phocyte specific kinase (LCK) expression in high grade
serous ovarian cancer.
Methods
LCK mRNA and protein (included in the reverse Phase
protein array (RPPA) data) expression was evaluated using
the ovarian cancer TCGA dataset. Gene expression was
compared between the LCK high and normal tumors was
compared. LCK protein expression was also evaluated
using IHC in an independent set of high grade serous
ovarian cancers, borderline tumors, benign cystadenomas,
and normal fallopian tubes (tissue of origin of serous
neoplasms).
Results
Using a SD of 1.86 above the mean as a cutoff, LCK
mRNA high samples were associated with both an
improved progression free and overall survival (p
Conclusions
LCK serves as a biomarker of prognostic and biological
importance in ovarian cancer. Ongoing investigation is
aimed at better understanding the immunological corre-
lates of high LCK expression in ovarian cancer.
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